Alto Neuroscience Statistics Share Statistics Alto Neuroscience has 27.07M
shares outstanding. The number of shares has increased by 0.39%
in one year.
Shares Outstanding 27.07M Shares Change (YoY) 0.39% Shares Change (QoQ) 0.01% Owned by Institutions (%) 63.89% Shares Floating 23.9M Failed to Deliver (FTD) Shares 2 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 1.64M, so 6.06% of the outstanding
shares have been sold short.
Short Interest 1.64M Short % of Shares Out 6.06% Short % of Float 7.7% Short Ratio (days to cover) 24.54
Valuation Ratios The PE ratio is -1.69 and the forward
PE ratio is -1.76.
Alto Neuroscience's PEG ratio is
-0.02.
PE Ratio -1.69 Forward PE -1.76 PS Ratio 0 Forward PS n/a PB Ratio 0.69 P/FCF Ratio -2.1 PEG Ratio -0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Alto Neuroscience.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 16.92,
with a Debt / Equity ratio of 0.11.
Current Ratio 16.92 Quick Ratio 16.92 Debt / Equity 0.11 Debt / EBITDA -0.25 Debt / FCF -0.34 Interest Coverage 49.9
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-808.3K Employee Count 76 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -33.97% in the
last 52 weeks. The beta is 2.02, so Alto Neuroscience's
price volatility has been higher than the market average.
Beta 2.02 52-Week Price Change -33.97% 50-Day Moving Average 3.66 200-Day Moving Average 3.17 Relative Strength Index (RSI) 82.78 Average Volume (20 Days) 100,207
Income Statement
Revenue n/a Gross Profit -502K Operating Income -68.61M Net Income -61.43M EBITDA -68.61M EBIT -62.81M Earnings Per Share (EPS) -2.5
Full Income Statement Balance Sheet The company has 168.23M in cash and 16.94M in
debt, giving a net cash position of 151.28M.
Cash & Cash Equivalents 168.23M Total Debt 16.94M Net Cash 151.28M Retained Earnings -138.4M Total Assets 157.88M Working Capital 141.72M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -47.42M
and capital expenditures -2.08M, giving a free cash flow of -49.5M.
Operating Cash Flow -47.42M Capital Expenditures -2.08M Free Cash Flow -49.5M FCF Per Share -2.01
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
